top of page

Cycloxan 500 mg Injection

SKU Cadila Healthcare Ltd
Prix d’origine

0,90$

Prix promotionnel

0,61$

Cycloxan 500 mg Injection is a potent anticancer agent designed to combat a range of malignant conditions, including various lymphomas, such as Hodgkin's and Burkitt's lymphoma, as well as multiple myeloma and certain types of leukemia. This medication works by targeting and inhibiting the growth of cancerous cells, thereby slowing down disease progression and providing a crucial therapeutic option for patients facing serious health challenges. In addition to its primary use in oncology, Cycloxan is also effective in treating nephrotic syndrome in children when other treatments have failed, showcasing its versatility in managing complex medical conditions. It is essential for patients to discuss any existing health issues and potential side effects with their healthcare provider prior to starting treatment, as Cycloxan can cause significant adverse effects. Regular monitoring during therapy is crucial to ensure safety and effectiveness. This medication should only be administered under the supervision of a qualified healthcare professional, who can tailor the treatment plan to the individual’s specific needs. Overall, Cycloxan 500 mg Injection represents an important tool in the fight against cancer and other serious diseases, improving patient outcomes when used appropriately.

Quantité

Active Pharmaceutical Ingredient

Cyclophosphamide 500 mg

Uses

• Cycloxan 500 mg injection is primarily used in the treatment of various types of lymphomas, including Hodgkin's and Non-Hodgkin's lymphoma. These conditions involve the malignant growth of lymphatic tissues, and Cycloxan 500 mg injection helps to combat these cancers effectively. Patients may receive this treatment as part of a comprehensive chemotherapy regimen. Its use can lead to improved outcomes and quality of life for individuals diagnosed with these diseases.
• This medication is also indicated for the management of acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL). Cycloxan 500 mg injection works by targeting rapidly dividing cancer cells, thus aiding in the reduction of leukemic cells in the blood and bone marrow. This is particularly beneficial for patients facing aggressive forms of leukaemia. The timely administration of Cycloxan 500 mg injection can play a crucial role in achieving remission.
• Cycloxan 500 mg injection is effective in treating multiple myeloma, a cancer that affects plasma cells in the bone marrow. By using Cycloxan 500 mg injection, healthcare providers aim to reduce the number of malignant plasma cells, which can lead to improved bone health and overall well-being. This treatment option is often integrated into a broader therapeutic strategy to enhance patient outcomes. Regular monitoring during treatment with Cycloxan 500 mg injection ensures that patients receive optimal care.
• In addition, Cycloxan 500 mg injection is utilized in the treatment of certain solid tumors, including ovarian cancer and neuroblastomas. These cancers can be particularly challenging to treat, and Cycloxan 500 mg injection helps by targeting the cancer cells directly. It is often administered in conjunction with other therapies to maximize effectiveness. The use of Cycloxan 500 mg injection can significantly contribute to the management of these complex conditions.

Benefits

Cycloxan 500 mg Injection belongs to the group of medicines called alkylating agents used to treat malignant diseases such as Hodgkin's disease (cancer of the lymphatic system), mixed-cell type lymphoma, lymphocytic lymphoma, histiocytic lymphoma, multiple myeloma (cancer of plasma cells), Burkitt's lymphoma, leukaemia (blood cancer), neuroblastoma (cancer commonly found in the adrenal glands), retinoblastoma (eye cancer), adenocarcinoma of the ovary, mycosis fungoides, Ewing's sarcoma (cancer in and around the bones), small cell lung cancer, advanced/metastatic neuroblastoma and breast carcinoma. Cycloxan 500 mg works by stopping or slowing the growth of cancer cells in the body. Thereby, Cycloxan 500 mg helps treat cancer. Additionally, Cycloxan 500 mg Injection is used to treat minimal change nephrotic syndrome (kidney disease) in pediatric patients. Cyclophosphamide 500 mg Injection suppresses the body's immune system, thereby helping treat nephrotic syndrome.

Side Effects

Cycloxan 500 mg Injection may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• Bruising
• Bleeding
• Slow healing existing wounds
• Mouth sores
• Tiredness
• Decrease in the amount of urine
• Weakness

Common Side Effects

• Leukopenia
• Bladder bleeding
• Serious Injection
• Infertility
• Nausea and vomiting
• Bone marrow suppression
• Hemorrhagic cystitis
• Stomach ache
• Darkening of the nails/skin
• Diarrhoea
• Thinning of hair
• Alopecia (Hair Loss)
• Change in texture and colour of the hair
• Profound gonadotoxicity
• Lethargy

How To Use

Cycloxan 500 mg Injection is administered intravenously (into a vein) by a health care professional, nurse or doctor in a medical facility. The frequency and dosage of Cycloxan 500 mg Vial injection are decided by your health care professional or doctor. You should inform your healthcare professional or doctor if you face any serious side effects. Do not self-administer Cycloxan 500 mg.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Cycloxan Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Cycloxan 500 mg Injection should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Cycloxan Injection and report any unusual symptoms or changes in kidney function to their doctor. The dose of Cycloxan 500 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Cycloxan 500 mg. Cycloxan 500 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Cyclophosphamide 500 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Cycloxan Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Cycloxan 500 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Cancer Chemotherapy Injection Cycloxan may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Cycloxan 500 mg Vial may be unsafe during pregnancy as limited animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Cycloxan 500 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Cycloxan 500 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Cycloxan Injection.

bottom of page